Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_assertion description "[Epigenetic inactivation of Plk2 via aberrant CpG methylation in the transcriptional regulatory elements of the gene is a common event in B cell neoplasia, whereas epigenetic inactivation of Plk3 is exceedingly rare in lymphomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_assertion evidence source_evidence_literature NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_assertion SIO_000772 16868416 NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_assertion wasDerivedFrom befree-20150227 NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_assertion wasGeneratedBy ECO_0000203 NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.
- befree-20150227 importedOn "2015-02-27" NP318377.RA871lY4aZvbxb0_baulgevmJSsETBfkLsiVt6F1Hjf1E130_provenance.